Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Coeptis Therapeutics Hldgs Inc (NQ: COEP )

1.200 +0.050 (+4.35%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 51,916
Open 1.090
Bid (Size) 1.110 (25)
Ask (Size) 1.200 (25)
Prev. Close 1.150
Today's Range 1.080 - 1.200
52wk Range 0.8090 - 12.13
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
Via Benzinga

Performance

YTD
-39.45%
-39.45%
1 Month
+18.81%
+18.81%
3 Month
-25.47%
-25.47%
6 Month
-14.29%
-14.29%
1 Year
-81.54%
-81.54%

More News

Read More
BioRestorative Therapies And 3 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Inventiva Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
How the Internet Turned Us Into Horrible Investors
Via InvestorPlace
Potential acquisition of VyGen-Bio would Strengthen Coeptis Therapeutics (NASDAQ: COEP) oncology pipeline by obtaining exclusive, worldwide ownership rights to GEAR™ Platform
Via Get News
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Acquisition Rights Obtained for Combinatorial Immuno-Oncology Treatments Using Multi-Antigen CAR T Technology, Cell Therapy for Multiple Cancers: Coeptis Therapeutics (NASDAQ: COEP)
Via Get News
Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2023
Via Benzinga
Acquisition Rights Obtained for Combinatorial Immuno-Oncology Treatments Using Multi-Antigen CAR T Technology, Cell Therapy for Multiple Cancers: Coeptis Therapeutics (NASDAQ: COEP)
Via Viz Release
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Is Near Intelligence (NIR) Stock Down 17% Today?
Via InvestorPlace
Why Is NuCana (NCNA) Stock Down 36% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Is First Republic Bank (FRC) Stock Up 29% Today?
Via InvestorPlace
Why Is Coeptis Therapeutics (COEP) Stock Up 14% Today?
Via InvestorPlace
Why Motorsport Games Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
BioMedNewsBreaks – Coeptis Therapeutics Holdings Inc. (NASDAQ: COEP) Tech Spotlighted in Article in Peer-Reviewed Translational Medicine Journal
Via Investor Brand Network
Translational Medicine Journal Features Multi-Antigen CAR T Technology, Cell Therapy, and In Vitro Diagnostics with Multiple Cancer Types: Coeptis Therapeutics Holdings, Inc (NASDAQ: COEP)
Via Get News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.